Search

everythinglearnresearchcommunity

for

Search:↓

The drinkable supplement increased hair growth and was safe for women with hair loss.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Female pattern hair loss does not significantly affect sexual dysfunction.

Skin hormone levels change significantly after menopause.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Long-term hair dye use may increase testosterone levels in women.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Experts made a guide to help doctors evaluate women with too much hair growth.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Low estrogen compared to androgen may cause female hair loss.

Menopause can cause oral health issues like dry mouth and burning sensations.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Asthma and high testosterone increase Covid-19 severity, while progesterone protects young women.

Preparing and learning about menopause can improve women's quality of life as they approach this phase.